QurAlis

Cambridge, MA · Founded 2016 · Privately Held (backing)

Developer of precision therapeutics and tools designed for amyotrophic lateral sclerosis and other neurodegenerative diseases with genetically validated targets. QurAlis is based in Cambridge, MA and was founded in 2016. Its last reported valuation was $178 million in Mar 2023. It has raised $158 million across 4 recorded rounds; the latest was a $20 million early-stage round in Aug 2025.

Last reported valuation
$178.0M
Oct 2026
Priced at
—
Total raised
$158.4M
Last round
Early Stage VC
Aug 2025

Who backs QurAlis?

21 investors
InvestorType
Alexandria Venture InvestmentsOther
Johnson & Johnson Innovation - JLABSOther
Polaris PartnersVenture capital
Dolby Family VenturesVenture capital
SV Health InvestorsVenture capital
EQT Life SciencesVenture capital
Mission BioCapitalVenture capital
Mitsui Global InvestmentOther
Pimlico Pond InvestmentsFamily office
ALS Investment Fund—
+ 11 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

QurAlis investors

21 investors are on record for QurAlis, including Alexandria Venture Investments, Johnson & Johnson Innovation - JLABS, Polaris Partners and Dolby Family Ventures. By type, the record holds 5 venture capital firms and 1 family office. The early-stage round in Aug 2025 drew 19 investors.

Free account
More of QurAlis with a free account
  • ·The complete investor list: 21 names
  • ·Watch QurAlis: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 21 firms already write checks for companies like QurAlis. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View